Defining the role of panitumumab in colorectal cancer

Axel Grothey

Research output: Contribution to journalReview article

6 Scopus citations


Panitumumab is the first fully human anti-EGFR monoclonal antibody available for the treatment of advanced colorectal cancer. The drug appears to be well tolerated and has demonstrated antitumor activity and clinical benefit both as a single agent and in combination with cytotoxic chemotherapy.

Original languageEnglish (US)
Pages (from-to)10-14+16
JournalCommunity Oncology
Issue number10 SUPPL. 4
StatePublished - Oct 1 2006


ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Grothey, A. (2006). Defining the role of panitumumab in colorectal cancer. Community Oncology, 3(10 SUPPL. 4), 10-14+16.